title: Dynorphin inhibits basal forebrain cholinergic neurons by pre- and postsynaptic mechanisms.
abstract: CONCLUSIONS
  The basal forebrain is an important component of the ascending arousal system and may be a key site through which the orexin neurons promote arousal. It has long been known that orexin-A and -B excite basal forebrain cholinergic neurons, but orexin-producing neurons also make the inhibitory peptide dynorphin. Using whole-cell recordings in brain slices, we found that dynorphin-A directly inhibits basal forebrain cholinergic neurons via κ-opioid receptors, and decreases afferent excitatory synaptic input to these neurons. While the effects of dynorphin-A and orexin-A desensitize over multiple applications, co-application of dynorphin-A and orexin-A produces a sustained response that reverses depending on the membrane potential of basal forebrain cholinergic neurons. At -40 mV the net effect of the co-application is inhibition by dynorphin-A, whereas at -70 mV the excitatory response to orexin-A prevails.
  The basal forebrain (BF) is an essential component of the ascending arousal systems and may be a key site through which the orexin (also known as hypocretin) neurons drive arousal and promote the maintenance of normal wakefulness. All orexin neurons also make dynorphin, and nearly all brain regions innervated by the orexin neurons express kappa opiate receptors, the main receptor for dynorphin. This is remarkable because orexin excites target neurons including BF neurons, but dynorphin has inhibitory effects. We identified the sources of dynorphin input to the magnocellular preoptic nucleus and substantia innominata (MCPO/SI) in mice and determined the effects of dynorphin-A on MCPO/SI cholinergic neurons using patch-clamp recordings in brain slices. We found that the orexin neurons are the main source of dynorphin input to the MCPO/SI region, and dynorphin-A inhibits MCPO/SI cholinergic neurons through κ-opioid receptors by (1) activation of a G protein-coupled inwardly rectifying potassium current, (2) inhibition of a voltage-gated Ca(2+) current and (3) presynaptic depression of the glutamatergic input to these neurons. The responses both to dynorphin-A and to orexin-A desensitize, but co-application of dynorphin-A and orexin-A produces a sustained response. In addition, the polarity of the response to the co-application depends on the membrane potential of BF neurons; at -40 mV the net effect of the co-application is inhibition by dynorphin-A, whereas at -70 mV the excitatory response to orexin-A prevails. This suggests that depending on their state of activation, BF cholinergic neurons can be excited or inhibited by signals from the orexin neurons.
authors.affiliation: Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, 02215, USA.
authors.forename: L L
authors.initials: LL
authors.lastname: Ferrari
authors.affiliation: Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, 02215, USA.
authors.forename: L J
authors.initials: LJ
authors.lastname: Agostinelli
authors.affiliation: National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD, 20892-1453, USA.
authors.forename: M J
authors.initials: MJ
authors.lastname: Krashes
authors.affiliation: Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, 02215, USA.
authors.forename: B B
authors.initials: BB
authors.lastname: Lowell
authors.affiliation: Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, 02215, USA.
authors.forename: T E
authors.initials: TE
authors.lastname: Scammell
authors.affiliation: Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, 02215, USA.
authors.forename: E
authors.initials: E
authors.lastname: Arrigoni
mesh_terms: D000818:Animals; D015220:Calcium Channels / Q000378:metabolism; D059329:Cholinergic Neurons / Q000378:metabolism* / Q000502:physiology; D004399:Dynorphins / Q000378:metabolism*; D051676:G Protein-Coupled Inwardly-Rectifying Potassium Channels / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D000068797:Orexins / Q000378:metabolism; D011301:Preoptic Area / Q000166:cytology / Q000378:metabolism* / Q000502:physiology; D011957:Receptors, Opioid / Q000378:metabolism; D013377:Substantia Innominata / Q000166:cytology / Q000378:metabolism* / Q000502:physiology; D013569:Synapses / Q000378:metabolism* / Q000502:physiology; D055366:Synaptic Potentials
chemical_list: D015220:Calcium Channels; D051676:G Protein-Coupled Inwardly-Rectifying Potassium Channels; D000068797:Orexins; D011957:Receptors, Opioid; D004399:Dynorphins